Nova Announces Pricing of Upsized Private Offering of $650 Million of 0.00% Convertible Senior Notes due 2030
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 03 2025
0mins
Should l Buy NVMI?
Source: PRnewswire
Nova's Convertible Notes Offering: Nova announced the pricing of $650 million in 0.00% Convertible Senior Notes due 2030, increasing from a previously planned $500 million, with an option for initial purchasers to buy an additional $100 million. The offering is set to close on September 5, 2025.
Use of Proceeds and Corporate Strategy: The net proceeds, estimated at approximately $631.5 million, will be used for capped call transactions and general corporate purposes, including potential mergers and acquisitions, although no specific agreements are currently in place.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NVMI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NVMI
Wall Street analysts forecast NVMI stock price to fall
7 Analyst Rating
5 Buy
2 Hold
0 Sell
Moderate Buy
Current: 443.550
Low
335.00
Averages
355.25
High
390.00
Current: 443.550
Low
335.00
Averages
355.25
High
390.00
About NVMI
Nova Ltd, former Nova Measuring Instruments Ltd,is an Israel based company which provides metrology solutions for the semiconductor manufacturing industry. The Company offers in-line Optical and x-ray stand-alone metrology systems, as well as integrated optical metrology systems, which are attached directly to wafer fabrication process equipment. Its metrology systems measure various film thickness and composition properties, as well as critical-dimension (CD) variables during various front-end and back-end of line steps in the semiconductor wafer fabrication process. Its product portfolio includes a set of in-situ, integrated and stand-alone metrology platforms suited for dimensional, films and material metrology measurements for process control across multiple semiconductor manufacturing process steps. Its products include NovaScan 2040, NovaScan 3090Next, Nova i500, Nova T500, Nova T600, Nova V2600 TSV metrology system among others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Nova Measuring Instruments Q4 Earnings Beat Expectations
- Earnings Surprise: Nova Measuring Instruments reported a Q4 non-GAAP EPS of $2.14, beating expectations by $0.02, which reflects the company's strong performance in the market and boosts investor confidence.
- Significant Revenue Growth: The company achieved revenue of $222.6 million in Q4, representing a 14.3% year-over-year increase, surpassing market expectations by $1.77 million, indicating sustained demand for its products and further solidifying its market position.
- Optimistic Future Outlook: Management provided a revenue forecast for Q1 2026, estimating between $222 million and $232 million, slightly below the consensus of $223.55 million, yet still demonstrating stable growth potential and reflecting confidence in future performance.
- Earnings Guidance: The expected diluted GAAP EPS for Q1 2026 is projected to be between $1.90 and $2.02, while the non-GAAP EPS is anticipated to range from $2.13 to $2.25, showcasing the company's ongoing enhancement in profitability.
See More
Nova Reports 31% Revenue Growth in 2025 Financial Results
- Significant Revenue Growth: Nova's total revenue for 2025 reached $880.6 million, a 31% increase from $672.4 million in 2024, demonstrating strong market demand and the company's ability to expand in the semiconductor manufacturing sector.
- Record Net Income: The company reported a GAAP net income of $259.2 million for 2025, with earnings per share of $7.96, significantly up from $183.7 million and $5.75 in 2024, reflecting ongoing improvements in profitability.
- Stable Gross Margin: The gross margin for 2025 was 57.4%, slightly down from 57.6% in 2024, yet indicating robust cost control and operational efficiency, ensuring sustainable profitability.
- Optimistic Outlook: Management anticipates continued growth in Q1 2026, projecting GAAP net income per share between $1.90 and $2.02, highlighting confidence in future market opportunities and the effectiveness of strategic positioning.
See More
Nova Reports Record Revenue and Profitability for 2025
- Strong Quarterly Performance: In Q4 2025, Nova achieved revenue of $222.6 million, a 14% year-over-year increase, with net income of $64.7 million, reflecting a 23% growth compared to the same quarter last year, indicating robust demand and profitability in the semiconductor market.
- Record Annual Revenue: For the full year 2025, Nova reported a record revenue of $880.6 million, up 31% year-over-year, with net income reaching $259.2 million, a 38% increase from 2024, showcasing significant market share gains in optical, materials, and chemical metrology products.
- Improving Gross Margin: The gross margin for Q4 2025 was 57.6%, up from 56.7% in Q3, demonstrating positive progress in cost control and operational efficiency, which enhances future profitability prospects.
- Optimistic Outlook: Management expects Q1 2026 revenue to be between $222 million and $232 million, with diluted GAAP EPS projected at $1.90 to $2.02, reflecting confidence in future market demand and continued growth potential.
See More
Nova Measuring Instruments Set to Release Q4 Earnings on February 12
- Earnings Announcement Date: Nova Measuring Instruments is set to announce its Q4 2023 earnings on February 12 before market open, with a consensus EPS estimate of $2.12, reflecting a 9.3% year-over-year growth, indicating sustained profitability.
- Revenue Growth Expectations: The anticipated revenue for Q4 is $220.83 million, representing a 13.4% year-over-year increase, showcasing the company's steady sales growth amid strong market demand.
- Consistent Outperformance: Over the past two years, Nova has beaten EPS and revenue estimates 100% of the time, demonstrating financial consistency and reliability, which enhances investor confidence.
- Forecast Revision Trends: In the last three months, both EPS and revenue estimates have seen one upward revision with no downward adjustments, reflecting analysts' optimistic outlook on the company's future performance, potentially driving stock price increases.
See More
Harel Insurance Sells KBWB ETF Shares Worth $330 Million
- Share Reduction: Harel Insurance disclosed on February 3, 2026, that it sold 4,177,000 shares of the Invesco KBW Bank ETF (KBWB), amounting to an estimated $330 million transaction, indicating a diminished confidence in this investment.
- Market Impact: The sale resulted in a $326.68 million decline in the value of its KBWB position, reflecting negative market movements and raising concerns about the future profitability of the banking sector amid changing interest rates.
- Strategic Shift: While reducing its KBWB holdings, Harel Insurance increased investments in healthcare (TEVA and XLV) and technology (GOOGL, NVMI, and SMH), suggesting a strategic pivot towards sectors expected to benefit from improving economic conditions and rising corporate spending on AI.
- ETF Performance Overview: As of February 2, 2026, KBWB was priced at $87.64, up 26.2% over the past year; however, in a declining interest rate environment, the potential for modest gains in bank ETFs like KBWB may necessitate cautious investor evaluation of future market performance.
See More
Harel Insurance Sells $330 Million in KBWB Shares
- Share Sale Scale: Harel Insurance disclosed in its SEC filing on February 3, 2026, that it sold 4,177,000 shares of the Invesco KBW Bank ETF (KBWB), with an estimated transaction value of approximately $330 million, reflecting its sensitivity to market dynamics.
- Asset Management Changes: This transaction resulted in a decline of $326.68 million in Harel's quarter-end position value, indicating a 2.9% negative impact on its assets under management (AUM), suggesting a need for reevaluation of its investment strategy.
- Portfolio Adjustment Strategy: Following the sale of KBWB shares, Harel holds only 620 shares valued at about $52,000, indicating a potential shift towards increasing investments in healthcare and technology sectors to navigate economic uncertainties.
- Market Environment Impact: With two rate cuts by the Federal Reserve, investors are cautious about the future performance of bank ETFs like KBWB, anticipating that lower interest rates will pressure banks' net interest margins and profits, potentially leading to slower growth in ETF returns.
See More
Nova Measuring Instruments Q4 Earnings Beat Expectations
- Earnings Surprise: Nova Measuring Instruments reported a Q4 non-GAAP EPS of $2.14, beating expectations by $0.02, which reflects the company's strong performance in the market and boosts investor confidence.
- Significant Revenue Growth: The company achieved revenue of $222.6 million in Q4, representing a 14.3% year-over-year increase, surpassing market expectations by $1.77 million, indicating sustained demand for its products and further solidifying its market position.
- Optimistic Future Outlook: Management provided a revenue forecast for Q1 2026, estimating between $222 million and $232 million, slightly below the consensus of $223.55 million, yet still demonstrating stable growth potential and reflecting confidence in future performance.
- Earnings Guidance: The expected diluted GAAP EPS for Q1 2026 is projected to be between $1.90 and $2.02, while the non-GAAP EPS is anticipated to range from $2.13 to $2.25, showcasing the company's ongoing enhancement in profitability.
See More
Nova Reports 31% Revenue Growth in 2025 Financial Results
- Significant Revenue Growth: Nova's total revenue for 2025 reached $880.6 million, a 31% increase from $672.4 million in 2024, demonstrating strong market demand and the company's ability to expand in the semiconductor manufacturing sector.
- Record Net Income: The company reported a GAAP net income of $259.2 million for 2025, with earnings per share of $7.96, significantly up from $183.7 million and $5.75 in 2024, reflecting ongoing improvements in profitability.
- Stable Gross Margin: The gross margin for 2025 was 57.4%, slightly down from 57.6% in 2024, yet indicating robust cost control and operational efficiency, ensuring sustainable profitability.
- Optimistic Outlook: Management anticipates continued growth in Q1 2026, projecting GAAP net income per share between $1.90 and $2.02, highlighting confidence in future market opportunities and the effectiveness of strategic positioning.
See More
Nova Reports Record Revenue and Profitability for 2025
- Strong Quarterly Performance: In Q4 2025, Nova achieved revenue of $222.6 million, a 14% year-over-year increase, with net income of $64.7 million, reflecting a 23% growth compared to the same quarter last year, indicating robust demand and profitability in the semiconductor market.
- Record Annual Revenue: For the full year 2025, Nova reported a record revenue of $880.6 million, up 31% year-over-year, with net income reaching $259.2 million, a 38% increase from 2024, showcasing significant market share gains in optical, materials, and chemical metrology products.
- Improving Gross Margin: The gross margin for Q4 2025 was 57.6%, up from 56.7% in Q3, demonstrating positive progress in cost control and operational efficiency, which enhances future profitability prospects.
- Optimistic Outlook: Management expects Q1 2026 revenue to be between $222 million and $232 million, with diluted GAAP EPS projected at $1.90 to $2.02, reflecting confidence in future market demand and continued growth potential.
See More
Nova Measuring Instruments Set to Release Q4 Earnings on February 12
- Earnings Announcement Date: Nova Measuring Instruments is set to announce its Q4 2023 earnings on February 12 before market open, with a consensus EPS estimate of $2.12, reflecting a 9.3% year-over-year growth, indicating sustained profitability.
- Revenue Growth Expectations: The anticipated revenue for Q4 is $220.83 million, representing a 13.4% year-over-year increase, showcasing the company's steady sales growth amid strong market demand.
- Consistent Outperformance: Over the past two years, Nova has beaten EPS and revenue estimates 100% of the time, demonstrating financial consistency and reliability, which enhances investor confidence.
- Forecast Revision Trends: In the last three months, both EPS and revenue estimates have seen one upward revision with no downward adjustments, reflecting analysts' optimistic outlook on the company's future performance, potentially driving stock price increases.
See More
Harel Insurance Sells KBWB ETF Shares Worth $330 Million
- Share Reduction: Harel Insurance disclosed on February 3, 2026, that it sold 4,177,000 shares of the Invesco KBW Bank ETF (KBWB), amounting to an estimated $330 million transaction, indicating a diminished confidence in this investment.
- Market Impact: The sale resulted in a $326.68 million decline in the value of its KBWB position, reflecting negative market movements and raising concerns about the future profitability of the banking sector amid changing interest rates.
- Strategic Shift: While reducing its KBWB holdings, Harel Insurance increased investments in healthcare (TEVA and XLV) and technology (GOOGL, NVMI, and SMH), suggesting a strategic pivot towards sectors expected to benefit from improving economic conditions and rising corporate spending on AI.
- ETF Performance Overview: As of February 2, 2026, KBWB was priced at $87.64, up 26.2% over the past year; however, in a declining interest rate environment, the potential for modest gains in bank ETFs like KBWB may necessitate cautious investor evaluation of future market performance.
See More
Harel Insurance Sells $330 Million in KBWB Shares
- Share Sale Scale: Harel Insurance disclosed in its SEC filing on February 3, 2026, that it sold 4,177,000 shares of the Invesco KBW Bank ETF (KBWB), with an estimated transaction value of approximately $330 million, reflecting its sensitivity to market dynamics.
- Asset Management Changes: This transaction resulted in a decline of $326.68 million in Harel's quarter-end position value, indicating a 2.9% negative impact on its assets under management (AUM), suggesting a need for reevaluation of its investment strategy.
- Portfolio Adjustment Strategy: Following the sale of KBWB shares, Harel holds only 620 shares valued at about $52,000, indicating a potential shift towards increasing investments in healthcare and technology sectors to navigate economic uncertainties.
- Market Environment Impact: With two rate cuts by the Federal Reserve, investors are cautious about the future performance of bank ETFs like KBWB, anticipating that lower interest rates will pressure banks' net interest margins and profits, potentially leading to slower growth in ETF returns.
See More
